They recovered the known immune evasion factors Stat1 and Serpin Family B Member 9 (Serpinb9) and identified the cancer testis antigen ADAM Metallopeptidase Domain 2 (Adam2) as an immune modulator, whose expression is induced by KrasG12D and further elevated by immunotherapy (Dervovic et al., 2023). The gene discussed is ADAM2; the disease is cancer.